Skip to main content
Personalis, Inc. logo

Personalis, Inc. — Investor Relations & Filings

Ticker · PSNL ISIN · US71535D1063 LEI · 549300EZ2NYFK7H0US48 US Human health and social work activities
Open in API
Filings indexed 482 across all filing types
Latest filing 2026-05-20 Regulatory Filings
Country US United States of America
Listing US PSNL

About Personalis, Inc.

https://www.personalis.com/

Personalis, Inc. is a company specializing in advanced cancer genomics that provides sequencing and data analysis solutions to transform the active management of cancer. The company's core technology is the NeXT Platform, which supports a suite of advanced genomic tests. Key offerings include NeXT Personal®, an ultra-sensitive, personalized liquid biopsy test for detecting molecular residual disease (MRD) and cancer recurrence earlier than standard imaging. The company also offers NeXT Dx™, a comprehensive tumor profiling service that analyzes the exome to help guide targeted therapy decisions. For its biopharmaceutical partners, Personalis provides the ImmunoID NeXT® platform, a biomarker analysis tool that supports the development of personalized cancer therapies and vaccines. By combining deep genomic sequencing with advanced analytics, Personalis aims to provide critical insights for clinicians and researchers to enable personalized treatment strategies.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 91% confidence The document is a U.S. SEC Form 8-K (“Current Report”) filed under the Securities Exchange Act, specifically Item 8.01 “Other Events,” announcing expanded Medicare coverage. It does not present actual financial statements or constitute an earnings release, proxy, capital change, or other specialized category. As a general regulatory announcement in Form 8-K, it falls under the fallback code for general regulatory filings.
2026-05-20 English
8-K - Personalis, Inc. (0001527753) (Filer)
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an SEC Form 8-K, Item 5.07, disclosing the certified results of proposals voted on at the company’s 2026 annual meeting of stockholders, including vote counts for each matter. This matches the “Declaration of Voting Results & Voting Rights Announcements” category.
2026-05-13 English
8-K - Personalis, Inc. (0001527753) (Filer)
Regulatory Filings Classification · 85% confidence The document is a United States SEC Form 8-K “Current Report” dated May 12, 2026, reporting a non-financial “Other Event” (expansion of Medicare coverage). It does not contain substantive financial statements or detailed presentations and serves as a general disclosure under the Exchange Act. Such filings fall under the catch-all category for miscellaneous regulatory announcements (“Regulatory Filings”).
2026-05-13 English
S-3ASR - Personalis, Inc. (0001527753) (Filer)
Capital/Financing Update Classification · 90% confidence The document is a Securities and Exchange Commission Form S-3 registration statement and accompanying base prospectus by Personalis, Inc. under the Securities Act of 1933. It provides the terms for potential offerings of common stock, preferred stock, debt securities, and warrants, including a sales agreement prospectus. This is clearly a long-form filing to facilitate fundraising and changes to the capital structure (i.e., registering new securities for sale). Under the provided taxonomy, this falls squarely into “Capital/Financing Update” (CAP). It is neither an annual report, earnings release, proxy statement, nor audit report, nor is it merely an announcement of a report publication.
2026-05-07 English
8-K - Personalis, Inc. (0001527753) (Filer)
Earnings Release Classification · 85% confidence The document is a Form 8-K filing reporting Item 2.02 “Results of Operations and Financial Condition,” and attaches a press release announcing quarterly financial results for the period ended March 31, 2026. This constitutes an initial announcement of periodic financial results (key highlights only), which matches the definition of an Earnings Release (ER). Q1 2026
2026-05-07 English
4 - Personalis, Inc. (0001527753) (Issuer)
Director's Dealing
2026-03-17 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.